Tony Reid
Company: EpicentRx
Job title: Chief Executive & Scientific Officer
Seminars:
Discussion Panel: Debating the Promise of Combinational Strategies with TGF-β 1:00 pm
day: Day Two
Exploring the Clinical Stage TGF-β Fusion Protein Expressing Oncolytic Virus, AdAPT-001 9:00 am
Highlighting the safety and tolerability of TGF-β targeting OV, AdAPT-001 Using correlative studies for measuring expression in the clinic Discussing neutralizing TGF-β for improving checkpoint inhibitorsRead more
day: Day Two